Search by Drug Name or NDC
NDC 14789-0116-05 Erythromycin Lactobionate 500 mg/10mL Details
Erythromycin Lactobionate 500 mg/10mL
Erythromycin Lactobionate is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nexus Pharmaceuticals Inc.. The primary component is ERYTHROMYCIN LACTOBIONATE.
Product Information
| NDC | 14789-0116 |
|---|---|
| Product ID | 14789-116_f62e4489-4e7b-4347-9c6a-3f132f10b2d2 |
| Associated GPIs | 03100050502105 |
| GCN Sequence Number | 009252 |
| GCN Sequence Number Description | erythromycin lactobionate VIAL 500 MG INTRAVEN |
| HIC3 | W1D |
| HIC3 Description | MACROLIDE ANTIBIOTICS |
| GCN | 40601 |
| HICL Sequence Number | 004020 |
| HICL Sequence Number Description | ERYTHROMYCIN LACTOBIONATE |
| Brand/Generic | Generic |
| Proprietary Name | Erythromycin Lactobionate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Erythromycin Lactobionate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/10mL |
| Substance Name | ERYTHROMYCIN LACTOBIONATE |
| Labeler Name | Nexus Pharmaceuticals Inc. |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215290 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 14789-0116-05 (14789011605)
| NDC Package Code | 14789-116-05 |
|---|---|
| Billing NDC | 14789011605 |
| Package | 5 VIAL, GLASS in 1 BOX (14789-116-05) / 10 mL in 1 VIAL, GLASS (14789-116-07) |
| Marketing Start Date | 2021-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |